NNelo Trade
← Back to Market News
November 09, 2026 at 01:36 PM UTC

Vistagen Therapeutics, Inc. reports additional corporate update

Vistagen Therapeutics, Inc. filed an 8-K covering other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: November 09, 2026 at 01:34 PM UTC

Open official source
Vistagen Therapeutics, Inc. reports additional corporate update | Nelo Trade